Nerve blocks and ablation therapy for the treatment of (Peripheral nerve blocks and nerve ablation)
Customize your policy alerts
Sign up for care_continuum Policy n05698 alerts
Get alerted when Policy n05698 changes without checking for updates manually.
Monitor payer policy activity
Policy governs medical necessity and utilization management guidance for peripheral nerve blocks and nerve ablation procedures (diagnostic and therapeutic) for Commercial and Medicare lines of business.
Significant updates were made to the coverage indications of this medical policy to align with current medical recommendations/standards of care and to align more closely with industry standards for coverage.
Policy now provides explicit guidance for Utilization Management Coordinators (nurse reviewers) regarding medical necessity determinations for nerve blocks and ablation therapies.
Coverage Criteria and Scope
General coverage approach
Covered when ALL of the following are met:
Significant updates were made to coverage indications and CPT/HCPCS codes were reviewed and updated; reviewers should apply referenced LCD/LCA/MCG guidance where applicable.
Coverage is subject to contract language and state/federal laws, which take precedence over this medical policy. Member-specific benefit documents (for example, Certificate of Coverage, Evidence of Coverage, or Summary Plan Descriptions) define contractual terms and will be considered first when determining eligibility and coverage; coverage may differ by plan. For Medicare members, applicable CMS coverage statements, including National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs), apply. Reviewers should apply those contract and regulatory requirements before relying on this policy guidance.
This summary does not enumerate specific conditions labeled Not Medically Necessary (NMN). Instead, services that do not meet the updated coverage indications set forth in this policy or that are excluded by a member's benefit contract may be considered not medically necessary. Significant updates were made to the coverage indications and CPT/HCPCS coding during the most recent review; reviewers should use the revised indications and applicable contract terms when assessing medical necessity.
Codes and Referenced Guidance
| CPT/HCPCS | CPT/HCPCS codes reviewed and updated (specific codes not listed in document) |
| A57452 | Local Coverage Article: Billing and Coding: Peripheral Nerve Blocks |
| L36850 | Local Coverage Determination (LCD): Peripheral Nerve Blocks |
| MCG A-1033 | MCG Nerve Block, Occipital |
Prior Authorization, Documentation, and Provider Requirements
Prior authorization — use policy & updated coding for medical necessity
Utilization Management Coordinators (nurse reviewers) must apply this policy when determining medical necessity for peripheral nerve blocks and ablation therapies; prior authorization requirements may reflect the updated CPT/HCPCS coding that was reviewed and updated during the annual policy revision.
- Apply the updated coverage indications in this policy when making medical necessity determinations.
- Be aware that CPT/HCPCS codes were reviewed and updated and prior authorization rules may have changed accordingly.
Step therapy — document conservative care and follow referenced guidance
Reviewers must confirm that conservative management steps and alignment with industry/CMS standard of care have been considered before approval; this policy references conservative therapy expectations but does not list specific stepwise requirements or durations, so reviewers should defer to referenced CMS LCD/LCA and MCG guidance for details.
- Document prior conservative therapies attempted and rationale if advancing to block/ablation.
- If local CMS LCD/LCA or MCG criteria specify step therapy requirements, apply those referenced criteria.
- Because the document does not enumerate exact durations or modalities, follow referenced guidance for specific step therapy definitions.
Documentation — indication, nerve targeted, and rationale required
Clinical documentation must state whether the procedure is diagnostic or therapeutic, identify the specific nerve targeted, and provide the clinical rationale for the diagnostic or therapeutic block/ablation; reviewers should also follow contractual benefit documents and applicable CMS LCD/LCA when evaluating documentation.
- Indicate purpose of procedure: diagnostic vs therapeutic.
- Specify the exact nerve targeted (e.g., occipital nerve) and clinical rationale.
- Include referenced benefit/coverage documentation when applicable (CMS LCD/LCA).
Denial risk if procedure does not meet revised coverage indications
Services that do not meet the updated coverage indications may be denied; the policy was materially updated to align with current standards of care and industry guidance, so failure to meet the revised indications or applicable contractual/CMS requirements creates a denial risk.
- Apply the revised coverage indications from this policy when adjudicating claims or prior authorizations.
- If service conflicts with member benefit contract, state/federal law, or CMS LCD/LCA, it may be denied per the disclaimer.
Clinical Background
Peripheral nerve blocks are procedures intended to temporarily disrupt pain signal transmission for either diagnostic purposes (to isolate the pain source) or therapeutic purposes (to relieve pain when the pain generator is known). Nerve ablation—via chemical, thermal, radiofrequency, cryotherapy, or other modalities—aims to reduce acute or chronic pain by destroying nerve tissue to prevent transmission of pain signals. This policy provides guidance for Utilization Management reviewers on medical necessity determinations for peripheral nerve blocks and ablation procedures and was updated to align the coverage indications with current medical standards of care and industry guidance.
Key Definitions
Conservative Care and Prior Treatment
Frequency and Interval Guidance
Imaging and Procedural Expectations
Imaging expectations: defer to CMS LCD/LCA guidance
This policy does not specify imaging expectations for peripheral nerve blocks or ablations; reviewers should reference applicable CMS guidance (LCD/A and Local Coverage Article) when evaluating imaging or fluoroscopy use.
- Imaging expectations are not specified in this document.
- Refer to CMS Local Coverage Article A57452 and LCD L36850 for billing/coding and imaging considerations.
Exclusions and Not Covered Services
This document does not list explicit procedural exclusions. Whether a given peripheral nerve block or ablation procedure is excluded depends on the member's benefit contract and any applicable CMS/LCD/MCG guidance. Reviewers should defer to the member’s plan documents and referenced coverage guidance when determining whether a service is not covered.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.